Search research articles
Contact Us
Filters
Showing results (191-200 of 434) with videos related to
Page
of 44
Sort By:
Journal of Neuropathology and Experimental Neurology
|
November 13, 2004
Loss of tumor suppressor in lung cancer-1 (TSLC1) expression in meningioma correlates with increased malignancy grade and reduced patient survival
Ezequiel I Surace, Eriks Lusis, Yoshinori Murakami, et al.
Annals of Neurology
|
February 21, 2013
Reduced microglial CX3CR1 expression delays neurofibromatosis-1 glioma formation
Winnie W Pong, Samantha B Higer, Scott M Gianino, et al.
Contemporary Clinical Trials
|
December 19, 2012
Development of an international internet-based neurofibromatosis Type 1 patient registry
Kimberly J Johnson, Ibrahim Hussain, Katherine Williams, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
June 6, 2014
Neurofibromatosis type 1 and chronic neurological conditions in the United States: an administrative claims analysis
Chinwe C Madubata, Margaret A Olsen, Dustin L Stwalley, et al.
Genes & Development
|
September 30, 2010
Neurofibromatosis-1 regulates neuroglial progenitor proliferation and glial differentiation in a brain region-specific manner
Da Yong Lee, Tu-Hsueh Yeh, Ryan J Emnett, et al.
Seminars in Cell & Developmental Biology
|
June 9, 2016
Contextual signaling in cancer
Laura J Smithson, Corina Anastasaki, Ran Chen, et al.
Pediatrics
|
January 2, 2009
Neurofibromatosis type 1 revisited
Virginia C Williams, John Lucas, Michael A Babcock, et al.
Neoplasia (New York, N.Y.)
|
October 28, 2008
The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP
Katherine Striedinger, Scott R VandenBerg, Gilson S Baia, et al.
Molecular and Cellular Biology
|
June 22, 2002
Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation
Michaela Livia Bajenaru, Yuan Zhu, Nicolé M Hedrick, et al.
Neoplasia (New York, N.Y.)
|
February 27, 2020
Erratum to "KIAA1549-BRAF Expression Establishes a Permissive Tumor Microenvironment Through NFκB-Mediated CCL2 Production" [Neoplasia, Volume: 21, Issue:1, (2019) 52-60]
Ran Chen, Chanel Keoni, Christopher A Waker, et al.
Page
of 44
Search research articles
Search
Showing results (191-200 of 434) with videos related to
Sort By:
Page
of 44
Journal of Neuropathology and Experimental Neurology
|
November 13, 2004
Loss of tumor suppressor in lung cancer-1 (TSLC1) expression in meningioma correlates with increased malignancy grade and reduced patient survival
Ezequiel I Surace, Eriks Lusis, Yoshinori Murakami, et al.
Annals of Neurology
|
February 21, 2013
Reduced microglial CX3CR1 expression delays neurofibromatosis-1 glioma formation
Winnie W Pong, Samantha B Higer, Scott M Gianino, et al.
Contemporary Clinical Trials
|
December 19, 2012
Development of an international internet-based neurofibromatosis Type 1 patient registry
Kimberly J Johnson, Ibrahim Hussain, Katherine Williams, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
June 6, 2014
Neurofibromatosis type 1 and chronic neurological conditions in the United States: an administrative claims analysis
Chinwe C Madubata, Margaret A Olsen, Dustin L Stwalley, et al.
Genes & Development
|
September 30, 2010
Neurofibromatosis-1 regulates neuroglial progenitor proliferation and glial differentiation in a brain region-specific manner
Da Yong Lee, Tu-Hsueh Yeh, Ryan J Emnett, et al.
Seminars in Cell & Developmental Biology
|
June 9, 2016
Contextual signaling in cancer
Laura J Smithson, Corina Anastasaki, Ran Chen, et al.
Pediatrics
|
January 2, 2009
Neurofibromatosis type 1 revisited
Virginia C Williams, John Lucas, Michael A Babcock, et al.
Neoplasia (New York, N.Y.)
|
October 28, 2008
The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP
Katherine Striedinger, Scott R VandenBerg, Gilson S Baia, et al.
Molecular and Cellular Biology
|
June 22, 2002
Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation
Michaela Livia Bajenaru, Yuan Zhu, Nicolé M Hedrick, et al.
Neoplasia (New York, N.Y.)
|
February 27, 2020
Erratum to "KIAA1549-BRAF Expression Establishes a Permissive Tumor Microenvironment Through NFκB-Mediated CCL2 Production" [Neoplasia, Volume: 21, Issue:1, (2019) 52-60]
Ran Chen, Chanel Keoni, Christopher A Waker, et al.
Page
of 44